Back to Search
Start Over
Response to PARP Inhibition in BARD1 -Mutated Refractory Neuroblastoma.
- Source :
-
The New England journal of medicine [N Engl J Med] 2024 Aug 15; Vol. 391 (7), pp. 659-661. - Publication Year :
- 2024
- Subjects :
- Humans
Drug Resistance, Neoplasm genetics
Piperazines therapeutic use
Treatment Outcome
Germ-Line Mutation
Female
Child, Preschool
Chemoradiotherapy, Adjuvant methods
Neuroblastoma genetics
Neuroblastoma pathology
Neuroblastoma therapy
Phthalazines therapeutic use
Poly(ADP-ribose) Polymerase Inhibitors therapeutic use
Tumor Suppressor Proteins genetics
Ubiquitin-Protein Ligases genetics
Neoplasm Recurrence, Local drug therapy
Neoplasm Recurrence, Local genetics
Bone Marrow Neoplasms secondary
Bone Marrow Neoplasms therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1533-4406
- Volume :
- 391
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- The New England journal of medicine
- Publication Type :
- Report
- Accession number :
- 39141861
- Full Text :
- https://doi.org/10.1056/NEJMc2403316